These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8617182)

  • 21. Felbamate monotherapy: implications for antiepileptic drug development.
    Theodore WH; Albert P; Stertz B; Malow B; Ko D; White S; Flamini R; Ketter T
    Epilepsia; 1995 Nov; 36(11):1105-10. PubMed ID: 7588454
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of felbamate on phenytoin and carbamazepine serum concentrations.
    Graves NM; Holmes GB; Fuerst RH; Leppik IE
    Epilepsia; 1989; 30(2):225-9. PubMed ID: 2647472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiepileptic drugs in development: prospects for the near future.
    Leppik IE
    Epilepsia; 1994; 35 Suppl 4():S29-40. PubMed ID: 8174517
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Felbamate in the treatment of Lennox-Gastaut syndrome: results of a 12-month open-label study following a randomized clinical trial.
    Dodson WE
    Epilepsia; 1993; 34 Suppl 7():S18-24. PubMed ID: 8243374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Felbamate as add-on therapy.
    Li LM; Nashef L; Moriarty J; Duncan JS; Sander JW
    Eur Neurol; 1996; 36(3):146-8. PubMed ID: 8738944
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Isobolographic and subthreshold analysis of interactions among felbamate and four conventional antiepileptic drugs in pentylenetetrazole-induced seizures in mice.
    Borowicz KK; Luszczki JJ; Czuczwar SJ
    Epilepsia; 2004 Oct; 45(10):1176-83. PubMed ID: 15461671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Felbamate. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in epilepsy.
    Palmer KJ; McTavish D
    Drugs; 1993 Jun; 45(6):1041-1065. PubMed ID: 7691493
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effect of felbamate on plasma levels of carbamazepine and its metabolites.
    Albani F; Theodore WH; Washington P; Devinsky O; Bromfield E; Porter RJ; Nice FJ
    Epilepsia; 1991; 32(1):130-2. PubMed ID: 1985822
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Felbamate monotherapy: controlled trial in patients with partial onset seizures.
    Sachdeo R; Kramer LD; Rosenberg A; Sachdeo S
    Ann Neurol; 1992 Sep; 32(3):386-92. PubMed ID: 1416808
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long-term use of felbamate: clinical outcomes and effect of age and concomitant antiepileptic drug use on its clearance.
    White JR; Leppik IE; Beattie JL; Walczak TS; Tran TA; Rarick JO; Vaher P
    Epilepsia; 2009 Nov; 50(11):2390-6. PubMed ID: 19563346
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aplastic anemia in a patient receiving felbamate for complex partial seizures.
    Pennell PB; Ogaily MS; Macdonald RL
    Neurology; 1995 Mar; 45(3 Pt 1):456-60. PubMed ID: 7898696
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is the interaction between felbamate and valproate against seizures induced by 4-aminopyridine and pentylenetetrazole in mice beneficial?
    Cuadrado A; Amat G; Armijo JA
    Pharmacol Res; 2003 Aug; 48(2):183-92. PubMed ID: 12798671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Felbamate: 1997 update.
    Pellock JM; Brodie MJ
    Epilepsia; 1997 Dec; 38(12):1261-4. PubMed ID: 9578519
    [No Abstract]   [Full Text] [Related]  

  • 34. Interaction of felbamate with several other antiepileptic drugs against seizures induced by maximal electroshock in mice.
    Gordon R; Gels M; Wichmann J; Diamantis W; Sofia RD
    Epilepsia; 1993; 34(2):367-71. PubMed ID: 8453946
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Felbamate in experimental model of status epilepticus.
    Mazarati AM; Baldwin RA; Sofia RD; Wasterain CG
    Epilepsia; 2000 Feb; 41(2):123-7. PubMed ID: 10691107
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of felbamate on valproic acid disposition in healthy volunteers: inhibition of beta-oxidation.
    Hooper WD; Franklin ME; Glue P; Banfield CR; Radwanski E; McLaughlin DB; McIntyre ME; Dickinson RG; Eadie MJ
    Epilepsia; 1996 Jan; 37(1):91-7. PubMed ID: 8603632
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Felbamate in the treatment of refractory partial-onset seizures.
    Jensen PK
    Epilepsia; 1993; 34 Suppl 7():S25-9. PubMed ID: 8243375
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A neuropharmacological evaluation of felbamate as a novel anticonvulsant.
    White HS; Wolf HH; Swinyard EA; Skeen GA; Sofia RD
    Epilepsia; 1992; 33(3):564-72. PubMed ID: 1592038
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Felbamate in therapy-resistant epilepsy: an Italian experience. Felbamate Italian Study Group.
    Avanzini G; Canger R; Dalla Bernardina B; Vigevano F
    Epilepsy Res; 1996 Nov; 25(3):249-55. PubMed ID: 8956923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Secondary mania associated with the use of felbamate.
    Hill RR; Stagno SJ; Tesar GE
    Psychosomatics; 1995; 36(4):404-6. PubMed ID: 7652143
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.